Endocrine Regulations (Jan 2025)

The ERN1 signaling pathway of unfolded protein controls the expression of EDEM1 and its hypoxic regulation in glioblastoma cells

  • Minchenko Oleksandr H.,
  • Hrebennykova Vita O.,
  • Viletska Yuliia M.,
  • Hnatiuk Oksana S.,
  • Sliusar Myroslava Y.,
  • Kozynkevych Halyna E.,
  • Minchenko Dmytro O.

DOI
https://doi.org/10.2478/enr-2025-0001
Journal volume & issue
Vol. 59, no. 1
pp. 1 – 9

Abstract

Read online

Objective. For the effective growth of malignant tumors, including glioblastoma, the necessary factors involve endoplasmic reticulum (ER) stress, hypoxia, and the availability of nutrients, particularly glucose. The ER degradation enhancing alpha-mannosidase like protein 1 (EDEM1) is involved in ER-associated degradation (ERAD) targeting misfolded glycoproteins for degradation in an N-glycan-independent manner. EDEM1 was also identified as a new modulator of insulin synthesis and secretion. The present study aims to investigate the regulation of the EDEM1 gene expression in U87MG glioblastoma cells by hypoxia and glucose or glutamine deprivations depending on the knockdown of ERN1 (endoplasmic reticulum to nucleus signaling 1) with the intent to reveal the role of ERN1 signaling in the regulation of this gene expression and function in tumorigenesis.

Keywords